InvestorsHub Logo
Followers 91
Posts 11310
Boards Moderated 0
Alias Born 06/06/2014

Re: F1ash post# 111397

Sunday, 07/16/2017 3:43:40 PM

Sunday, July 16, 2017 3:43:40 PM

Post# of 459987
You're correct. The company increased its equity authorization by $50MM not for giggles or as a grand bargaining stratagem fantasy but because it is raising capital to fund our Phase 2/3. We did not have a partner on the near horizon and clinical development must proceed. The company has not heard anything about Biogen proceeding with follow-up MS testing; they would relay this if they did (sorry but I'll burst anybody's fantasy bubble now, it would not be "kept secret". This isn't high school).

If 18 month results are good, if there is robust dose dependency, and if Ariana comes up with feasible correlatives, I'll bet we'll get a partner. If the MS testing is fruitful, it might be Biogen.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News